Tinavi Medical Technologies Co (688277) Fair Value & Analysis

Healthcare · CN · Market cap 8.3B CNY

Analysis

Tinavi Medical Technologies Co (688277) currently trades at ¥19.19, while our model-based Fair Value estimate is ¥12.75 — implying the stock looks roughly 33.6% overvalued today. We read business quality at 80/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Tinavi Medical Technologies Co.,Ltd. engages in the research and development, production, sale, market, service, and clinical application of orthopedic surgery robots and related technologies. The company offers TiRobot II, an orthopedic robotic system to create an operation center; TiRobot, an orthopedic robotic system used in implants in surgery for spine and trauma; 5G remote surgery systems; and TiRobot instrument comprising hand surgery locating, as well as cervical, hip, and foot and ankle surgery toolkits. It also provides robotic-guided orthopedic surgical systems; and supporting equipment and consumables. In addition, the company is involved in investment management business; and provision of technical services. The company was founded in 2010 and is based in Beijing, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.